Order Article Reprints

Gkountakos A, Centonze G, Vita E, Belluomini L, Milella M, Bria E, Milione M, Scarpa A, Simbolo M. Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines. 2022; 10(2):277. https://doi.org/10.3390/biomedicines10020277

Gkountakos, Anastasios, Giovanni Centonze, Emanuele Vita, Lorenzo Belluomini, Michele Milella, Emilio Bria, Massimo Milione, Aldo Scarpa, and Michele Simbolo. 2022. "Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance" Biomedicines 10, no. 2: 277. https://doi.org/10.3390/biomedicines10020277

Gkountakos, A., Centonze, G., Vita, E., Belluomini, L., Milella, M., Bria, E., Milione, M., Scarpa, A., & Simbolo, M. (2022). Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines, 10(2), 277. https://doi.org/10.3390/biomedicines10020277